Synthesis AI
United States
- San Francisco, California
- 28/04/2022
- Series A
- $17,000,000
Pioneering synthetic data technology to build more capable and ethical AI.
- Industry Software Development
- Website https://synthesis.ai/
- LinkedIn https://www.linkedin.com/company/synthesis-ai/
Related People
Yashar BehzadiFounder
United States -
San Francisco Bay Area
Proven executive, experienced technologist, and meticulous product lead with a history of delivering first-in-class products to market.
Specialties:
- Early venture strategy and financing
- Developing novel technologies
- New product introduction and market development across industries
- Building strong teams
- Leading complex and multifaceted product development programs
- Structuring and leading strategic partnerships with large companies
Highlights:
- Launched world's first digital medicines product system (ingestible sensor+pharmaceuticals+wearables+apps)
- Developed first AI-based diagnostic test for broad-spectrum mental illness based on a panel of biomarkers
- 8 years of experience building best-in-class wearables (FDA-approved, CE-marked)
- Pioneered synthetic data technologies for building more capable AI models
- 30+ patents across hardware & software (https://patents.justia.com/inventor/yashar-behzadi)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)